Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia
Mattea L. Tan, Dipannita Basu, Jacek M. Kwiecien, Rodney L. Johnson, Ram K. Mishra
Dive into the research topics of 'Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia'. Together they form a unique fingerprint.